Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Full Circle Healthcare: The Lingering Concerns and Challenges Left in COVID’s Wake

As vaccinations become the dominant part of the pandemic conversation and life reaches a new normal, what are the lingering challenges of those patients who suffered the effects of COVID-19, and what other concerns will exist? David Macfarlane, the Marketing Communications Manager for Medsphere, shared his thoughts with host James Kent on what he believed…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

As vaccinations become the dominant part of the pandemic conversation and life reaches a new normal, what are the lingering challenges of those patients who suffered the effects of COVID-19, and what other concerns will exist?

David Macfarlane, the Marketing Communications Manager for Medsphere, shared his thoughts with host James Kent on what he believed some of those challenges might be in the months, and possibly years, to come.

From Macfarlane’s perspective, there are many primary concerns once the pandemic starts to get into a manageable shape. “At the top of that list has got to be the challenge of long COVID,” Macfarlane said. “We’ve got a number of people for whom this disease is something that they’re going to have to be managing for weeks, and perhaps months, after it looks as though they are out of the woods.”

Is the healthcare system prepared for long-term health issues related to COVID-19? Macfarlane said it is something healthcare is starting to discuss. “I don’t know that the healthcare system is geared to deal with the number of people who might need long-term care, because it could be a significant number,” Macfarlane said.

With so many unknowns, having sharable information and data related to COVID-19 patients makes EHR (electronic health records) such a potentially valuable healthcare resource. “As EHR’s have evolved, it’s become clear that one of their biggest benefits is the use of big data,” Macfarlane said. These vast data sets allow healthcare resources to scan for similarities in patient backgrounds, symptoms, and how bodies react to the symptoms and response to certain medicines.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512